These data suggest that ASMC from COPD patients who do not respond to treatment with ICS, are characterized by reduced GR-c-Jun complex formation and increased expression of HDAC3 and HDAC5. The gene discussed is JUN; the disease is chronic obstructive pulmonary disease.